by In2Pharma | Dec 27, 2024 | News
Europe An update to Delegated Regulation (EU) 2024/1701, which amends Regulation (EC) No 1234/2008, has been published and will come into effect on 1 January 2025. This regulation addresses the examination of variations to the terms of marketing authorisations for...
by In2Pharma | Dec 2, 2024 | News
Europe As part of Regulation (EU) 2022/123, an EU platform has been realised to prevent, monitor, and manage any medicine shortages across the EU of centrally authorised medicines. The European Shortages Monitoring Platform (ESMP) has the purpose to facilitate...
by In2Pharma | Aug 26, 2024 | News
Europe We would like to inform you of a significant new EU regulation—the Ecodesign for Sustainable Products Regulation (ESPR)—which came into force on July 18th, 2024, replacing the previous 2009 legislation. This regulation is designed to make products more...
by In2Pharma | Jul 10, 2024 | News
Europe Extension of the IVD Regulation Transitional Periods Brussels, 30 May 2024 – The EU co-legislators have adopted an amendment to the In Vitro Diagnostics and Medical Devices Regulations (IVDR and MDR), extending the IVDR transitional provisions and adding a...
by In2Pharma | Jul 2, 2024 | News
Europe On 9/04/2024 CBG published three new implementing acts regarding the new legislation on packaging for veterinary medicines in Europe. The following implementing acts (IAs) have been published: Implementing regulation (EU) 2024/875: This regulation establishes a...
